Bioactive vitreous composition for bone implants, filaments...

A - Human Necessities – 61 – L

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61L 27/00 (2006.01) A61L 27/12 (2006.01) A61L 27/32 (2006.01) C03C 3/097 (2006.01) C03C 4/00 (2006.01) C03C 13/00 (2006.01) A61F 2/00 (2006.01) A61F 2/28 (2006.01)

Patent

CA 2075281

2075281 9112032 PCTABS00006 The invention relates to a bioactive vitreous composition for bone implantation which includes the following approximate percentages by weight of the following oxides: SiO2 from 40 to 55 %; P2O5 from 5 to 8 %; Cao (MgO) from 20 to 40 %; Na2 (K2O) from 20 to 30 %. The composition can be reduced to filaments without becoming ceramic by virtue of the addition of a total of not more than 9 % by weight of K2O and Al2O3, the percentage of Al2O3 being from 0.5 % to 2.5 %. The filaments thus obtained can be used to prepare products for bone implantation in the form of bundles of filaments, gauzes, nets or other fabrics, felts, "cotton-wools" and the like. The filaments can be reduced to particles of powders for the application, inter alia, of a coating layer of the vitreous composition to a permanent metal prosthesis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bioactive vitreous composition for bone implants, filaments... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bioactive vitreous composition for bone implants, filaments..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioactive vitreous composition for bone implants, filaments... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1585299

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.